|
Title
|
Published
|
Price
|
|
Biotechnology Sector
By: First Research, Inc.
The US biotechnology industry includes about 1,500 companies with combined annual revenue of about $70 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs
|
more...
Search inside this report
|
11/16/2009
|
$129.00
|
|
Monoclonal antibodies: 2009 update
By: Datamonitor
Introduction The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also
|
more...
|
11/2/2009
|
$7,600.00
|
|
Dealmaking and Industry Outlook: Neurological Disease
By: Decision Resources
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying
causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may
|
more...
|
11/2/2009
|
$2,250.00
|
|
Biotechnology (Pharmaceuticals) Report
By: Plimsoll Publishing Ltd.
The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation
|
more...
|
11/1/2009
|
$1,500.00
|
|
Three Bundled Reports 1: Dextrins: Food & Industrial 2: CWS (cold water swelling) / Spray Cooked starches 3: Physically Modified Starches each with Applications, Products and Markets
By: S. K. Patil and Associates
The three starch derivatives cover the most active areas of food ingredients to meet the growth of convenience, snacks, clean labeling.
Dextrin Report Dextrins belong to a class of low-molecular-weight carbohydrates degradation products made from
|
more...
|
11/1/2009
|
$3,850.00
|
|
Worldwide Biotech - November 2009
By: Worldwide Videotex
Worldwide Biotech provides news and information on
biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese
|
more...
Search inside this report
|
11/1/2009
|
$25.00
|
|
Biotech Financial Reports - November 2009
By: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend
|
more...
Search inside this report
|
11/1/2009
|
$25.00
|
|
Biotech Equipment Update - November 2009
By: Worldwide Videotex
Biotech Equipment Update covers news and the latest
information about biotechnology lab and manufacturing
equipment and products. This includes new product and
technology announcements, as well as vendor research,
development, and manufacturing information.
|
more...
Search inside this report
|
11/1/2009
|
$25.00
|
|
Biotech Business - November 2009
By: Worldwide Videotex
Biotech Business provides detailed information on
biotechnology products and companies. It reports which
universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies
|
more...
Search inside this report
|
11/1/2009
|
$25.00
|
|
CWS (cold water swelling) / Spray Cooked starches - Applications, Products and Markets
By: S. K. Patil and Associates
Cold water swelling and spray cooked starches are marketed heavily for instant preparation and convenience aspects of food preparation. Granular cold water swelling/soluble starches are produced by treatment with an alcohol and a strong base
|
more...
|
11/1/2009
|
$975.00
|
|
Physically Modified Starches Applications, Products and Markets
By: S. K. Patil and Associates
Recent developments in starch technology are the development and marketing of physically modified starches that perform similar to chemically modified starches in food applications. National led this development by introducing product line under brand
|
more...
|
11/1/2009
|
$975.00
|
|
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis
By: Aruvian's R'search
The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the
|
more...
Search inside this report
|
11/1/2009
|
$175.00
|
|
Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy
By: Amadee & Company
This research provides an overview on what could become one of the most significant technological and economic events of the early 21st century: turning algae into fuel, i.e. algal oil, on a commercial scale. If
|
more...
Search inside this report
|
11/1/2009
|
$2,900.00
|
|
Global Stem Cell and Advanced Technologies Market
By: MarketsandMarkets
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and
|
more...
Search inside this report
|
11/1/2009
|
$4,650.00
|
|
Opportunities in Human Embryonic Stem Cell (hESC) Products
By: BioInformant Worldwide, L.L.C.
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. They are the most pluripotent of all stem cell
|
more...
Search inside this report
|
11/1/2009
|
$3,495.00
|
|
Dextrins Food & Industrial applications, Products & Markets
By: S. K. Patil and Associates
Dextrins belong to a class of low-molecular-weight carbohydrates degradation products made from starch manufactured by a process called pyrolysis. During pyrolysis, dry, powdered starch is treated with acid in a suitable reactor and heated
|
more...
|
11/1/2009
|
$2,900.00
|
|
Freedonia Focus on Biologicals
By: Freedonia Focus
This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment,
|
more...
|
10/31/2009
|
$500.00
|
|
Crop Protection China Market Opportunities and Challenges
By: CCM International Limited
China is a traditional agricultural country, with a total area of 5,000 billion square meters stricken by plant diseases and insect pests each year. With only 7% of the world’s arable land, China has fed
|
more...
|
10/30/2009
|
$8,150.00
|
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
By: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
|
more...
|
10/29/2009
|
$3,500.00
|
|
Acorda Therapeutics, Inc. - SWOT Analysis
By: Datamonitor
Datamonitor's Acorda Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Acorda Therapeutics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and
|
more...
Search inside this report
|
10/26/2009
|
$125.00
|
|
Future of Green Biotechnology in China
By: CCM International Limited
This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this field. The first edition of
|
more...
|
10/19/2009
|
$6,650.00
|
|
Biotechnology in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating
|
more...
Search inside this report
|
10/17/2009
|
$810.00
|
|
Scientific Research in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$810.00
|
|
Scientific Research & Development in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research & Development in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise,
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Biotechnology in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Title
|
Published
|
Price
|
(0 items)
